Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Type of study: non-rct experimental Number of citations: 18 Year: 2022 Authors: Siyu Wang, Meifeng Yang, Saige Yin, Yingxuan Zhang, Yue Zhang, Huiling Sun, Longjun Shu, Yixiang Liu, Zijian Kang, Naixin Liu, Jiayi Li, Ying Wang, Li He, Mingying Luo, Xinwang Yang Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Journal ranking: Q1 Key takeaways: OA-GI13, a novel amphibian-derived peptide, effectively reduces ultraviolet B-induced skin photodamage by increasing antioxidant levels and protecting the skin against UVB irradiation
documented side effect incidence rates across multiple studies involving over 200 patients
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
This allows us to identify any underlying issues or deficiencies that might be impacting your weight
US$ 20.30
US$ 22.73
US$ 22.16
US$ 29.16
US$ 25.81
